What Have We Learned about the Prevention of NMSC from Albino Patients from Malawi? Secondary Prevention Maintained over Time

Author:

Tomás-Velázquez Alejandra1ORCID,Moreno-Artero Ester2,Romero Javier3,Escalonilla Pilar4,Medina Isabel3,Petiti Gisela Hebe5,Redondo Pedro1ORCID

Affiliation:

1. Dermatology Department, Clínica Universidad de Navarra, 28027 Madrid, Spain

2. Dermatology Department, Hospital Universitario Galdakao, 48960 Galdakao, Spain

3. Romero y Medina Dermatology Clinic, 29640 Fuengirola, Spain

4. Dermatology Department, Complejo Asistencial de Ávila, 05071 Ávila, Spain

5. Dermatology Department, Consorci Sanitari Integral, Hospital Dos de Mayo, 08025 Barcelona, Spain

Abstract

Background: We have conducted cooperative campaigns focusing on albino patients in a rural area of Malawi. What have we learned? Methods: Three surgical campaigns were performed in Nkhotakota district (2019–2023). Albino clinical and tumor characteristics were collected. Results: Between 22 and 75 albinos were evaluated in each campaign (mean age < 28 years old). Most patients did not use sunscreen in a way that provided optimal photoprotection. Regarding tumors, the proportion of basal and squamous cell carcinomas ranged from 1:1 to almost 2:1. Of 156 albino patients, 34 attended more than once. However, of the 19 patients with 30 tumors operated on in 2021, only seven were assessed the following year (12 were lost to follow-up). At least 14 albinos with locally advanced tumors were evaluated. Conclusions: Distributing photoprotective clothing could be more efficient or perhaps an earlier measure of sunscreen in rural Africa as it does not require permanent repositioning. Very-high-risk patients (previous interventions with positive margins or high-risk tumors, intense actinic damage, and new tumors constantly appearing, especially those presenting SCCs) require close follow-up and treatment and represent our main target. Secondary prevention with Malawian collaboration and the use of teledermatology is essential for patient tracking, as they are able to offer curative treatments.

Funder

Beca Dermatólogos desde el corazón—La Roche Posay—and Ayudas a la Cooperación Fundación Quirón Salud

Publisher

MDPI AG

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3